CORC

在结果中检索

CORC

浏览/检索结果: 共27条，第1-10条 帮助

已选(0)清除 条数/页：   排序方式：
Molecular characterization of clinical responses to PD-1/PD-L1 inhibitors in non-small cell lung cancer: Predictive value of multidimensional immunomarker detection for the efficacy of PD-1 inhibitors in Chinese patients 期刊论文
THORACIC CANCER, 2019, 卷号: 10, 期号: 5
作者:  Song, Peng;  Cui, Xiaoxia;  Bai, Li;  Zhou, Xiangdong;  Zhu, Xiaoli
收藏  |  浏览/下载：27/0  |  提交时间：2019/12/05
The REACH Trial: A Randomized Controlled Trial Assessing the Safety and Effectiveness of the Spiration (R) Valve System in the Treatment of Severe Emphysema 期刊论文
RESPIRATION, 2019, 卷号: 97, 期号: 5
作者:  Li, Shiyue;  Wang, Guangfa;  Wang, Changhui;  Gao, Xinglin;  Jin, Faguang
收藏  |  浏览/下载：31/0  |  提交时间：2019/12/05
Management of anlotinib-related adverse events in patients with advanced non-small cell lung cancer: Experiences in ALTER-0303. 期刊论文
Thoracic cancer, 2019, 卷号: 10, 页码: 551-556
作者:  Si Xiaoyan;  Zhang Li;  Wang Hanping;  Zhang Xiaotong;  Wang Mengzhao
收藏  |  浏览/下载：34/0  |  提交时间：2019/11/19
A multicenter RCT of noninvasive ventilation in pneumonia-induced early mild acute respiratory distress syndrome 期刊论文
2019, 卷号: 23, 期号: 1, 页码: 300
作者:  He Hangyong;  Sun Bing;  Liang Lirong;  Li Yanming;  Wang He
收藏  |  浏览/下载：38/0  |  提交时间：2020/01/03
Molecular characterization of clinical responses to PD-1/PD-L1 inhibitors in non-small cell lung cancer: Predictive value of multidimensional immunomarker detection for the efficacy of PD-1 inhibitors in Chinese patients 期刊论文
2019, 卷号: 10, 期号: 5, 页码: 1303-1309
作者:  Song, Peng;  Cui, Xiaoxia;  Bai, Li;  Zhou, Xiangdong;  Zhu, Xiaoli
收藏  |  浏览/下载：17/0  |  提交时间：2020/01/03
Management of anlotinib-related adverse events in patients with advanced non-small cell lung cancer: Experiences in ALTER-0303 期刊论文
2019, 卷号: 10, 期号: 3, 页码: 551-556
作者:  Si, Xiaoyan;  Zhang, Li;  Wang, Hanping;  Zhang, Xiaotong;  Wang, Mengzhao
收藏  |  浏览/下载：13/0  |  提交时间：2020/01/03
Prognostic factors of refractory NSCLC patients receiving anlotinib hydrochloride as the third- or further-line treatment 期刊论文
CANCER BIOLOGY & MEDICINE, 2018, 卷号: 15, 期号: 4
作者:  Wang, Jing;  Zhao, Yizhuo;  Wang, Qiming;  Zhang, Li;  Shi, Jianhua
收藏  |  浏览/下载：3/0  |  提交时间：2019/12/04
Effect of Anlotinib as a Third-Line or Further Treatment on Overall Survival of Patients With Advanced Non-Small Cell Lung Cancer The ALTER 0303 Phase 3 Randomized Clinical Trial 期刊论文
JAMA ONCOLOGY, 2018, 卷号: 4, 期号: 11
作者:  Han, Baohui;  Li, Kai;  Wang, Qiming;  Zhang, Li;  Shi, Jianhua
收藏  |  浏览/下载：3/0  |  提交时间：2019/12/04
Effect of Anlotinib as a Third-Line or Further Treatment on Overall Survival of Patients With Advanced Non-Small Cell Lung Cancer: The ALTER 0303 Phase 3 Randomized Clinical Trial. 期刊论文
JAMA Oncology, 2018, 卷号: 4, 期号: 11, 页码: 1569-1575
作者:  Han, Baohui*;  Li, Kai*;  Wang, Qiming;  Zhang, Li;  Shi, Jianhua
收藏  |  浏览/下载：7/0  |  提交时间：2019/12/03
Effect of Anlotinib as a Third-Line or Further Treatment on Overall Survival of Patients With Advanced Non-Small Cell Lung Cancer: The ALTER 0303 Phase 3 Randomized Clinical Trial. 期刊论文
JAMA oncology, 2018, 卷号: 4, 页码: 1569-1575
作者:  Han Baohui;  Li Kai;  Wang Qiming;  Zhang Li;  Shi Jianhua
收藏  |  浏览/下载：5/0  |  提交时间：2019/11/26

©版权所有 ©2017 CSpace - Powered by CSpace